mbr-FPGS高效表达质粒增强Jurkat细胞对甲氨蝶呤的敏感性

叶酰多聚谷氨酸盐合成酶(Folylpolyglutamate synthetase,FPGS)是将化疗药物甲氨蝶呤(Methotrexate,MTX)转化成甲氨蝶呤多聚谷氨酸盐(MTXPG)的关键酶,其表达水平直接影响肿瘤细胞对MTX敏感性。与B细胞急性淋巴细胞白血病(B-ALL)相比,T细胞急性淋巴细胞白血病(T-ALL)细胞中FPGS表达水平低,因此对MTX不敏感。本实验室前期研究证实,位于BCL2基因3′-UTR区的一段长279 bp的DNA序列mbr具有显著的增强子效应。文章构建了含有mbr增强子样序列的FPGS表达质粒,用其转染Jurkat细胞后,分别以Westernblotting和MTT法检测FPGS表达水平及MTX对肿瘤细胞的抑制率。结果表明mbr能够显著提高FPGS表达质粒的表达水平,并有效增强Jurkat细胞对MTX的敏感性。这一结果为将基础研究结果应用于临床、提高MTX对T-ALL细胞的化疗疗效提供了新的思路。     

Poly (ADP‐ribose) polymerase‐1 binds to BCL2 major breakpoint region and regulates BCL2 expression

BCL2, originally identified as a proto‐oncogene in B‐cell lymphoma, is a key regulator of apoptosis. Although it is more than 200 kb in length, at least 70% of the t(14;18) translocation in follicular lymphomas occurs at the BCL2 major breakpoint region (mbr), located in the 3′‐untranslated region (3'‐UTR). We have previously found that the mbr is a regulatory element which positively regulates BCL2 expression and this regulatory function was closely associated with SATB1, which binds to a 37 bp mbr (37 mbr) in the 3′‐end of the mbr directly. However, the precise molecular mechanisms by which the mbr regulates gene expression are not fully understood. In this study, we purified Poly(ADP‐ribose) polymerase‐1 (PARP‐1) from the DNA–protein complexes formed by 37 mbr in Jurkat cells and demonstrated that PARP‐1 participates in the 37 mbr–protein complex's formation in vitro and in vivo. Functional analysis showed that overexpression of PARP‐1 decreases 37 mbr regulatory function and BCL2 expression. Conversely, knockdown of PARP‐1 with RNAi increases BCL2 expression. Taken together, the present findings indicate that PARP‐1 is a component of BCL2 37 mbr–protein complexes, and PARP‐1 is involved in the regulation of BCL2 expression. These findings are helpful in understanding the regulatory mechanisms of BCL2 expression. J. Cell. Biochem. 110: 1208–1218, 2010. Published 2010 Wiley‐Liss, Inc.